Bone Marrow TransplantationTransplantation, HomologousBone TransplantationGraft vs Host DiseaseBone MarrowBone Marrow CellsWhole-Body IrradiationLeukemiaBone and BonesAnemia, AplasticTransplantation ConditioningTransplantation, AutologousTransplantation ChimeraTissue DonorsBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalHematopoietic Stem Cell TransplantationHistocompatibility TestingLeukocyte TransfusionRecurrenceGraft vs Tumor EffectHistocompatibilityRadiation ChimeraLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionCyclophosphamideHematologic NeoplasmsLymphocyte DepletionRemission InductionGraft vs Leukemia EffectImmunosuppressive AgentsTransplantation, IsogeneicAcute DiseaseLymphocyte TransfusionHepatic Veno-Occlusive DiseaseGraft RejectionBone Marrow PurgingLeukemia, MyeloidImmunosuppressionMice, Inbred C57BLHematopoietic Stem CellsCombined Modality TherapyTime FactorsTreatment OutcomeChimeraT-LymphocytesBone RemodelingCyclosporineKidney TransplantationMyelodysplastic SyndromesTransplantation ImmunologyHematopoiesisNuclear FamilyLiver TransplantationSurvival AnalysisCytomegalovirus InfectionsActuarial AnalysisRetrospective StudiesHLA AntigensFatal OutcomeHematologic DiseasesMice, Inbred BALB CLymphoma, Non-HodgkinBone DensityBone Marrow DiseasesSevere Combined ImmunodeficiencySurvival RateCytarabineFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalHeart TransplantationPancytopeniaGranulocyte Colony-Stimulating FactorSpleenLeukocyte CountBone ResorptionBone Marrow ExaminationStem Cell TransplantationInfectionLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsImmunocompromised HostMethotrexateLymphomaGanciclovirEtoposideAntilymphocyte SerumCyclosporinsMultiple MyelomaNeoplasm, ResidualFlow CytometryLung TransplantationPrognosisBone Marrow NeoplasmsImmunophenotypingMice, Inbred C3HPneumonia, Viral